Owkin Announces Partnership with AstraZeneca to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer
recent articles
March 21, 2022: Today, Visiopharm launches Qualitopix™ for AI-driven standardization of tissue staining at USCAP 2022 is introducing its novel and unique Qualitopix™ solution to delegates at the United States and Canadian Academy of...
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions Collaboration builds on commitment to advance personalised healthcare by helping to improve access to new...
Led by Section 32 and Sanofi Ventures, funding will enable Nucleai to expand its commercial footprint in biopharma and further develop its state-of-the-art spatial biology platform TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, an AI-powered...
NEW YORK--(BUSINESS WIRE)--Paige, the global leader in AI-based diagnostic software in pathology, today launched its latest product, Paige Breast Lymph Node, an AI medical device software that helps pathologists detect if breast cancer has...
Proscia and Visiopharm: Partnership to improve clinical decision making for breast and colon cancer care HOERSHOLM, Denmark & PHILADELPHIA – March 22, 2022 – Proscia®, a leader in digital and computational pathology solutions, and...
BOSTON and CLEVELAND — March 10, 2022 — PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Cleveland Clinic today announced a five-year strategic collaboration that will focus on leveraging...
